LB Pharmaceuticals Balance Sheet
NASDAQ: LBRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LB Pharmaceuticals financial position
At the end of fiscal 2025, LB Pharmaceuticals reported total assets of $312.9 million, up 833.2% from a year earlier against total liabilities of $11.6 million. Shareholders' equity stood at $301.3 million, or 96.3% of assets. The company held $250.2 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 41.44, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
LB Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 |
|---|---|---|
| Cash & Equivalents | 250.17M | 22.98M |
| Short-Term Investments | 45.04M | 5.02M |
| Total Current Assets | 308.43M | 28.88M |
| Property, Plant & Equipment | 1.58M | 1.86M |
| Total Assets | 312.93M | 33.53M |
| Accounts Payable | 2.13M | 2.32M |
| Total Current Liabilities | 7.44M | 8.11M |
| Total Liabilities | 11.62M | 13.83M |
| Shareholders' Equity | 301.31M | -94.55M |
| Retained Earnings | -129.53M | -104.32M |
| Net Cash (Debt) | 295.21M | 28.00M |
| Shares Outstanding | 25.30M | 251.66K |
This table shows 2 annual periods of LB Pharmaceuticals's balance sheet, from FY 2025 back to FY 2024, across 12 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow LBRX's reporting calendar. What is a balance sheet?